{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:48:33Z","timestamp":1785797313580,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.berh.2017.09.014","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T09:33:46Z","timestamp":1508924026000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["What can palindromic rheumatism tell us?"],"prefix":"10.1016","volume":"31","author":[{"given":"Kulveer","family":"Mankia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2017.09.014_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archinte.1944.00210160025004","volume":"73","author":"Hench","year":"1944","journal-title":"Arch Int Med"},{"key":"10.1016\/j.berh.2017.09.014_bib2","first-page":"330","article-title":"Palindromic rheumatism","volume":"18","author":"Ansell","year":"1959","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10067-014-2569-3","article-title":"In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up","volume":"33","author":"Emad","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib4","first-page":"540","article-title":"Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism","volume":"26","author":"Gonzalez-Lopez","year":"1999","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03009748709165412","article-title":"Palindromic rheumatism. A clinical survey of sixty patients","volume":"16","author":"Hannonen","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib6","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3899\/jrheum.090025","article-title":"Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967\u201384","volume":"36","author":"Koskinen","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/ard.25.4.307","article-title":"Palindromic rheumatism","volume":"25","author":"Mattingly","year":"1966","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib8","first-page":"1240","article-title":"The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis","volume":"33","author":"Russell","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3899\/jrheum.120568","article-title":"Palindromic rheumatism with positive anticitrullinated peptide\/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study","volume":"39","author":"Sanmarti","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/03009741003604534","article-title":"Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism","volume":"39","author":"Tamai","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/ard.36.1.56","article-title":"Palindromic rheumatism. Clinical and serum complement study","volume":"36","author":"Wajed","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.39603","article-title":"Preclinical rheumatoid arthritis: progress toward prevention","volume":"68","author":"Mankia","year":"2016","journal-title":"Arthr Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms \u2013 a cohort study","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib15","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39297","article-title":"Autoantibodies in predicting rheumatoid arthritis in healthy relatives of rheumatoid arthritis patients","volume":"67","author":"Ramos-Remus","year":"2015","journal-title":"Arthr Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib18","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A\u00a0prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/annrheumdis-2015-208138","article-title":"Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis","volume":"75","author":"van Steenbergen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kev431","article-title":"Clinical expertise and its accuracy in differentiating arthralgia patients at risk for rheumatoid arthritis from other patients presenting with joint symptoms","volume":"55","author":"van Steenbergen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2017.09.014_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/annrheumdis-2014-205522","article-title":"Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI","volume":"74","author":"van Steenbergen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9343(92)90177-D","article-title":"Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis","volume":"93","author":"Guerne","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2017.09.014_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1756-185X.2012.01739.x","article-title":"A\u00a0multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran","volume":"15","author":"Khabbazi","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib24","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22755","article-title":"An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism","volume":"56","author":"Canete","year":"2007","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.berh.2017.09.014_bib25","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/art.21923","article-title":"Association of intermittent hydrarthrosis with MEFV gene mutations","volume":"54","author":"Canete","year":"2006","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.berh.2017.09.014_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bmj.1.5011.139","article-title":"Intermittent hydrarthrosis","volume":"1","author":"Mattingly","year":"1957","journal-title":"Br Med J"},{"key":"10.1016\/j.berh.2017.09.014_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2012-202087","article-title":"Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation","volume":"72","author":"Andres","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib28","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1136\/annrheumdis-2015-208235","article-title":"Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib29","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3028","article-title":"The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study","volume":"12","author":"van de Stadt","year":"2010","journal-title":"Arthr Res Ther"},{"key":"10.1016\/j.berh.2017.09.014_bib30","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/ar4536","article-title":"Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis","volume":"16","author":"van Steenbergen","year":"2014","journal-title":"Arthr Res Ther"},{"key":"10.1016\/j.berh.2017.09.014_bib31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3899\/jrheum.131545","article-title":"Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? a clinical and ultrasonographic study according to anticitrullinated protein antibody status","volume":"41","author":"Cabrera-Villalba","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/annrheumdis-2011-200077","article-title":"Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis","volume":"71","author":"Bugatti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00296-008-0654-0","article-title":"Magnetic resonance imaging of palindromic rheumatism","volume":"29","author":"Ueda","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2017.09.014_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.7863\/jum.2009.28.9.1193","article-title":"Association of ultrasonographic findings of synovitis with anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in patients with palindromic rheumatism during active episodes","volume":"28","author":"Chen","year":"2009","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.berh.2017.09.014_bib35","first-page":"17","article-title":"Predicting the progression of palindromic rheumatism to rheumatoid arthritis: the role of ultrasonography and anti-cyclic citrullinated peptide antibodies","volume":"18","author":"Chen","year":"2010","journal-title":"J\u00a0Med Ultrasound"},{"key":"10.1016\/j.berh.2017.09.014_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.6237","article-title":"FRI0102 Ultrasound and mri during flares of palindromic rheumatism reveal a distinct phenotype even in imminent ra","volume":"76","author":"Mankia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib37","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/keg268","article-title":"Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?","volume":"42","author":"Salvador","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2017.09.014_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/25.4.345","article-title":"HLA antigens in palindromic rheumatism and palindromic onset rheumatoid arthritis","volume":"25","author":"Fisher","year":"1986","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib39","first-page":"136","article-title":"HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis","volume":"11","author":"Gran","year":"1984","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib40","first-page":"470","article-title":"HLA antigens in palindromic rheumatism. An Italian study","volume":"7","author":"Barbieri","year":"1988","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib41","first-page":"441","article-title":"[Palindromic rheumatism. Immunologic survey and study of development in 43 cases]","volume":"53","author":"Bregeon","year":"1986","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.berh.2017.09.014_bib42","first-page":"2319","article-title":"HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis","volume":"29","author":"Maksymowych","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib43","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2006.052928","article-title":"Palindromic rheumatism: different genetic background implies a distinct disease entity","volume":"65","author":"Kim","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.09.014_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02032105","article-title":"Palindromic rheumatism in Israel \u2013 a disease entity? A survey of 34 patients","volume":"8","author":"Eliakim","year":"1989","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib45","first-page":"341","article-title":"Prophylactic colchicine therapy in palindromic rheumatism","volume":"9","author":"Schwartzberg","year":"1982","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/rheumatology\/27.1.79","article-title":"Sulphasalazine for palindromic rheumatism","volume":"27","author":"Golding","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib47","first-page":"35","article-title":"Palindromic rheumatism: a response to chloroquine","volume":"18","author":"Youssef","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.09.014_bib48","first-page":"41","article-title":"Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials","volume":"27","author":"Gonzalez-Lopez","year":"2000","journal-title":"J\u00a0Rheumatol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694217300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694217300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:17:36Z","timestamp":1761499056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694217300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521694217300311"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2017.09.014","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What can palindromic rheumatism tell us?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2017.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}